Progress, Potential, and Possibilities Podcast / Show

Ira Pastor

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

  1. 2d ago

    Everyone Dies: The Truth About Death We Avoid Talking About | Dr. Marianne Matzo

    Send us Fan Mail We spend enormous amounts of time trying to extend life - but almost no time learning how to deal with the fact that it ends. And that gap is creating enormous suffering for families. Dr. Marianne Matzo, Ph.D., FAAN is a nationally recognized gerontologist, hospice nurse, educator, researcher, and advocate whose career has been devoted to one of the most universal - and often avoided - human experiences: dying. Dr. Matzo is a Fellow of the American Academy of Nursing, one of the profession's highest honors, and served as Professor and the Frances E. and A. Earl Ziegler Chair in Palliative Care Nursing at the University of Oklahoma Health Sciences Center. Over a distinguished academic career, she helped shape the field of palliative care education, co-authoring the first palliative care nursing textbook published in the United States, now in its fifth edition. Dr. Matzo's research has explored everything from end-of-life communication and assisted dying to sexual health among people living with serious illness, helping to advance both clinical practice and public understanding. Following her retirement from full-time academia, Dr. Matzo launched the nonprofit organization Everyone Dies ( https://every1dies.org/ ), dedicated to public education about serious illness, dying, death, and bereavement. Through podcasts, educational resources, and children's literature, she is working to transform how Americans think about mortality and helping families navigate some of life's most difficult conversations with greater confidence, compassion, and clarity. Today we'll explore Dr. Matzo's remarkable career, the evolution of hospice and palliative care, why our culture struggles to discuss death, and what it would mean to build a society that approaches the end of life with wisdom rather than fear. #DeathEducation #PalliativeCare #HospiceCare #EndOfLifeCare #GriefSupport #Healthcare #MedicalEthics #Aging #Gerontology #AdvanceCarePlanning #HospiceNurse #PublicHealth #Longevity #DeathPositive #SeriousIllness #Caregiving #Wellness #Medicine #Bioethics #EveryoneDies Support the show

    1h 24m

  2. 4d ago

    From Supernova Physics to Fusion Energy: The Laser Experiments Changing Science - Dr. Mario Manuel, Ph.D. - General Atomics

    Send us Fan Mail What if we could recreate the inside of a star - not in theory, but inside a laboratory on Earth using the world’s most powerful lasers? Dr. Mario Manuel, Ph.D. is a plasma physicist and laser-science researcher at whose work sits at the frontier of fusion energy, laboratory astrophysics, high-energy-density physics, and advanced laser diagnostics. Trained in applied plasma physics and aerospace engineering, Dr. Manuel has spent his career developing new ways to visualize and understand the extreme electromagnetic environments created when ultra-powerful lasers interact with matter. Dr. Manuel's research has spanned some of the most ambitious scientific efforts underway today - from inertial fusion energy and plasma-instability control to recreating supernova-like shock waves in the laboratory and generating ultra-intense gamma-ray and particle beams using petawatt-class lasers.  Early in his career, Dr. Manuel helped pioneer advanced proton-radiography techniques capable of imaging invisible electric and magnetic fields inside laser-produced plasmas, work that opened new windows into the turbulent physics that can either enable or destroy fusion reactions. Today at General Atomics ( https://www.ga.com/ ), Dr. Manuel is involved in next-generation high-repetition-rate laser systems and the GALADRIEL ( https://www.ga.com/galadriel/ ) facility, where researchers are developing the automation, diagnostics, AI-driven optimization, and rapid experimental capabilities that may ultimately make practical laser fusion energy possible. His work also bridges into laboratory astrophysics, where miniature laser-driven plasmas are used to study the same collision-less shocks, turbulence, and magnetic-field generation processes that occur in supernova remnants and other extreme cosmic environments. With collaborations spanning facilities such as the National Ignition Facility in Livermore, California, and the OMEGA Laser Facility in Rochester, New York, along with partnerships across the fusion-energy and laboratory-astrophysics communities, Dr. Manuel represents a new generation of interdisciplinary scientists using ultra-powerful lasers not only to pursue practical fusion energy, but also to recreate and study some of the most extreme physical processes in the universe. From plasma turbulence and magnetic-field generation to collision-less shocks and high-energy particle acceleration, his work connects the quest for clean energy with the physics of stars, supernovae, and cosmic plasmas. #fusionenergy #nuclearfusion #nationalignitionfacility #laserscience #plasmaphysics #labastrophysics #supernova #gammaRays #particlephysics #inertialconfinementfusion #cleanenergy #futureofenergy #deeptech #sciencepodcast #generalatomics #livermore #omegaLaser #highenergyphysics #physics #aiinscience #fusionbreakthrough #scienceinterview Support the show

    1h 4m

  3. Jun 5

    The Future of AI in Pharma, Diagnostics & Precision Medicine | Bill Taranto, President and Founding Partner & Dr. David Rubin, Managing Director - Merck Global Health Innovation Fund

    Send us Fan Mail Over the last several years, artificial intelligence has transformed from a speculative concept in healthcare into one of the most heavily funded movements in pharmaceutical and biotech history. But in 2026, the conversation is changing. The question is no longer whether AI can generate molecules, analyze pathology slides, or identify patterns in clinical data. The real question is: which of these technologies can survive the complexity of biology, regulatory scrutiny, clinical validation, and real-world deployment? Today we’re joined once again by returning guest Bill Taranto, President and Founding Partner of the Merck Global Health Innovation Fund ( https://www.merckghifund.com/ ), alongside Managing Director, Dr. David Rubin, who brings a deep scientific background spanning molecular biology, oncology, precision medicine, and digital health investing. Together, Bill and David sit at a unique intersection of pharma strategy, venture investing, translational science, and clinical deployment. Through investments across AI-driven drug discovery, precision medicine, diagnostics, and digital health - including early involvement with companies like PathAI - they’ve had a front-row seat to what’s actually working in AI-enabled healthcare…and what still breaks down when these systems encounter real-world medicine. Today we’ll explore where AI is genuinely creating value across the pharmaceutical stack, why some approaches are beginning to achieve meaningful validation, what investors and pharma companies are now demanding beyond hype, and how entirely new experimental models - from organoids to AI-native biology platforms - may reshape the future of drug development. #AI #ArtificialIntelligence #DrugDiscovery #Biotech #Pharma #HealthcareAI #PrecisionMedicine #DigitalHealth #Oncology #PathAI #Roche #Biology #MachineLearning #BiotechInvesting #VentureCapital #Merck #DigitalPathology #ClinicalTrials #FutureOfMedicine #LifeSciences #AIHealthcare #MedicalInnovation #Biotechnology #CancerResearch #PrecisionOncology #Bioinformatics #HealthcareInnovation #Pharmaceuticals #MedTech #ProgressPotentialPossibilities Support the show

    1h 1m

  4. Jun 5

    When Survival Isn’t Enough: Reinventing Pediatric Recovery | Dr. Nicholas Holekamp, MD - Chief Health Transformation Officer, Ranken Jordan Pediatric Bridge Hospital

    Send us Fan Mail What if modern medicine has become incredibly good at saving children’s lives…but society still hasn’t figured out how to help many of those children truly live afterward? Dr. Nicholas Holekamp, MD is the Chief Health Transformation Officer at Ranken Jordan Pediatric Bridge Hospital in St. Louis ( https://rankenjordan.org/about-us/leadership/nicholas-holekamp-md/ ), one of only a handful of pediatric bridge hospitals in the United States and the only one of its kind in Missouri ( www.RankenJordanFoundation.org ). For more than two decades, Dr. Holekamp has helped pioneer a radically different approach to caring for children with complex medical conditions through Ranken Jordan’s innovative “Care Beyond the Bedside” model - a philosophy built around a deceptively simple but powerful idea: children heal better when they are active, engaged, social, and out of bed. Under Dr. Holekamp's leadership, Ranken Jordan evolved from a small 26-bed pediatric nursing facility into a nationally recognized 60-bed specialty hospital focused on helping medically complex children transition safely from intensive hospital care back to home and community life. A graduate of Dartmouth College and Saint Louis University School of Medicine, Dr. Holekamp completed his pediatric residency at Cardinal Glennon Children’s Medical Center before joining Ranken Jordan in 2000. Along the way, he has become one of the leading voices in pediatric complex care and transitional medicine. Dr. Holekamp's work has combined clinical care, hospital transformation, and research - including published studies demonstrating how movement, play, environment, and family-centered care can improve outcomes for medically fragile children while potentially reducing healthcare utilization and costs. Dr. Holekamp has been recognized for both his medical leadership and community impact, including receiving the Missouri Foundation for Health’s Dr. Corinne Walentik Leadership in Health Award and delivering a TEDxStLouis talk on the future of pediatric healing and healthcare transformation. Today, as Chief Health Transformation Officer, Dr. Holekamp is focused on sharing the lessons of Ranken Jordan with hospitals and healthcare systems across the country - challenging long-held assumptions about what healing environments for children should actually look like. #Pediatrics #ChildrensHospital #MedicalEthics #HealthcareInnovation #PediatricCare #Neurodevelopment #ChildrenWithMedicalComplexity #HealthcarePodcast #Medicine #PediatricMedicine #HospitalInnovation #CriticalCare #Bioethics #FamilyCenteredCare #HealthcareLeadership #MedicalResearch #VentilatorCare #Rehabilitation #PediatricRehabilitation #FutureOfHealthcare #HealthcareSystems #MedicalTechnology #ProgressPotentialPossibilities #HealthcareTransformation #PediatricICU Support the show

    57 min

  5. Jun 3

    How Computational Biology Is Reinventing Agriculture & Energy | Ofer Haviv - CEO, Casterra - President and CEO, Evogene

    Send us Fan Mail For decades, agriculture and energy were treated as separate worlds. But what happens when farms become part of the global energy infrastructure? Ofer Haviv joins us to discuss the rise of castor as a next-generation industrial crop, the future of sustainable aviation fuel, and how AI-driven biology is transforming agriculture itself. Ofer Haviv is CEO of Casterra ( https://casterra.co/ ) and longtime President and CEO of Evogene ( https://evogene.com/ ), one of the pioneers in computational biology and AI-driven agricultural innovation. For more than two decades, Ofer has helped lead the transformation of crop science from traditional breeding into a data-driven discipline powered by predictive biology, artificial intelligence, and advanced genomics. He played a key role in Evogene’s spin-off from Compugen in 2002 and has guided the company through its evolution into a global computational biology platform with applications spanning agriculture, human health, industrial biotechnology, and sustainable materials. Today, Ofer also serves as CEO of Casterra, an Evogene subsidiary focused on transforming castor farming into a scalable industrial platform for the future bioeconomy. Through elite castor seed varieties and integrated farming solutions, Casterra is helping address growing global demand for sustainable feedstocks used in biofuels, aviation fuel, lubricants, polymers, cosmetics, and other bio-based industries. With increasing pressure on the world to decarbonize transportation, strengthen energy security, and develop more sustainable industrial supply chains, Casterra’s work sits at the convergence of agriculture, climate technology, and renewable energy innovation. Ofer holds a degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant in Israel. #OferHaviv #Casterra #Evogene #Biofuels #SustainableAviationFuel #SAF #ClimateTech #Agriculture #AgTech #Biotech #AI #ArtificialIntelligence #ComputationalBiology #RenewableEnergy #GreenEnergy #FutureOfEnergy #IndustrialBiotech #Castor #SustainableFarming #EnergyTransition #Bioeconomy #CarbonNeutral #FutureTech #ClimateInnovation #CleanTech #Aviation #JetFuel #SustainableTechnology #FoodTech #PrecisionAgriculture Support the show

    42 min

  6. Jun 3

    The Invention That Revolutionized Wound Healing | Dr. Michael Morykwas - Co-Inventor - Vacuum Assisted Closure

    Send us Fan Mail Every once in a while, a simple question changes medicine forever. For decades, chronic and traumatic wounds were among the most frustrating problems in healthcare. Doctors could clean wounds, dress wounds, and hope for healing - but many patients remained trapped in cycles of infection, inflammation, and failed recovery. Then came one deceptively simple idea:  What happens if you apply vacuum? That question led to the creation of Vacuum Assisted Closure - better known worldwide as V.A.C.® Therapy ( https://www.solventum.com/en-us/home/medical/advanced-wound-care/negative-pressure-wound-therapy/vac-therapy/ ) - developed by plastic surgeon Dr. Louis Argenta and biomedical engineer Dr. Michael Morykwas ( https://www.renovoconcepts.com/michaelmorykwasbio ). The technology transformed wound care by using controlled negative pressure to remove fluid, stimulate blood flow, encourage tissue growth, and accelerate healing. What began as a bold experiment evolved into one of the most important advances in modern medicine, helping more than 20 million patients worldwide - from burn victims and diabetic patients to wounded soldiers returning from Iraq and Afghanistan. For this groundbreaking work, Drs. Argenta and Morykwas were inducted into the National Inventors Hall of Fame ( https://www.invent.org/inductees/michael-morykwas ). Today, we’re joined by Dr. Michael Morykwas - bioengineer, inventor, scientist, and lifelong tinkerer - to explore the origins of this revolutionary technology, the science behind mechanobiology and wound healing, the long road from prototype to global adoption, and what the future of regenerative medicine may look like next. Photo Credit - National Inventors Hall of Fame  #MichaelMorykwas #VACtherapy #WoundHealing #RegenerativeMedicine #Mechanobiology #BiomedicalEngineering #MedicalInnovation #NegativePressureWoundTherapy #TissueEngineering #HealthcareInnovation #PlasticSurgery #Bioengineering #MedicalBreakthrough #Inventor #NationalInventorsHallOfFame #RegenerativeScience #MilitaryMedicine #FutureOfMedicine #MedTech #SciencePodcast #InnovationPodcast #HealthcareTechnology #StemCells #WoundCare #MedicalScience Support the show

    42 min

  7. Jun 2

    The Next Evolution of T Cell Engagers in Oncology | Dr. Jack Silberstein - CEO, Deck Bio

    Send us Fan Mail For years, T cell therapies have transformed blood cancers - but solid tumors have remained one of the hardest problems in medicine. Now a new company called Deck Bio believes the issue isn’t just finding a better target...it’s that cancer may never have been a single-target disease in the first place. Dr. Jack Silberstein, Ph.D. is the Founder and CEO of Deck Bio ( https://deck.bio/ ), a biotechnology company developing next-generation T cell engager therapies designed to address one of the most persistent challenges in solid tumor immunotherapy: antigen heterogeneity and immune escape. Deck Bio’s platform takes a multi-target approach, engineering T cell receptors to simultaneously recognize multiple peptide-MHC (pMHC) complexes, with the goal of improving both tumor specificity and durable anti-tumor activity while reducing the on-target/off-tumor toxicity that has limited earlier T cell engager strategies. Prior to founding Deck Bio, Dr. Silberstein trained as an immunology Ph.D. at Stanford University, where he was a Bio-X interdisciplinary fellow, and later worked at Johns Hopkins University on early clinical and translational oncology studies, including work on AR-V7 as a resistance biomarker in prostate cancer and early immune checkpoint combination trials. His background spans both deep immunology and real-world clinical translation in oncology. Dr. Silberstein joins us following Deck Bio’s recent preclinical presentation at AACR 2026 in San Diego, where the company shared early data on its multi-pMHC targeting strategy. #DeckBio #JackSilberstein #Immunotherapy #CancerResearch #TCellEngagers #Biotech #AACR2026 #SolidTumors #CancerTherapy #TCellTherapy #PrecisionMedicine #Oncology #TCRTherapy #CancerInnovation #Biotechnology #ImmuneSystem #CellTherapy #CancerBreakthrough #SyntheticBiology #FutureOfMedicine Support the show

    31 min

  8. Jun 2

    AI vs Bureaucracy: Reinventing National Security Compliance from the Ground Up | Andrew Black - CEO, Kovr.ai

    Send us Fan Mail Most people assume national security delays are about technology. They’re not.  They’re about paperwork - and it can take up to two years just to deploy software the government already wants. Andrew Black is a national security entrepreneur, cybersecurity executive, and emerging technology strategist whose career has sat at the intersection of AI, defense, cyber risk, and global security operations. Andrew is currently the CEO of Kovr.ai ( https://kovr.ai/ ) an AI-native cyber compliance platform focused on one of the biggest bottlenecks in modern national security: getting software and cloud systems authorized for use in highly regulated and classified environments. Kovr.ai is using AI to automate complex compliance frameworks like FedRAMP and CMMC, helping organizations become “ATO-ready” (Authority to Operate) in minutes rather than months.   Andrew also now serves as Chief Strategy Officer of Fortreum  ( https://fortreum.com/ ) which recently acquired Kovr.ai Before joining Kovr.ai, Andrew led emerging technology initiatives at Amazon Web Services (AWS), where he worked with government leaders on next-generation capabilities spanning artificial intelligence, generative AI, quantum computing, high-performance computing, edge systems, and space technologies. Andrew's career has also included leadership roles at Gartner, advisory work with the Krach Institute for Tech Diplomacy at Purdue, venture investing with NextGen Venture Partners, and teaching national security and data analysis as adjunct faculty at Georgetown University Walsh School of Foreign Service. Earlier in his career, Andrew worked in counter-terrorism, threat modeling, and risk analytics, building data-driven systems to allocate anti-terrorism resources and anticipate geopolitical instability in frontier and conflict-affected regions. A graduate of University of St Andrews and Georgetown University, Andrew has spent two decades helping government and industry navigate increasingly complex technological and security landscapes - and today he’s focused on transforming how AI can accelerate trust, compliance, and operational readiness across the defense ecosystem. #AI #Cybersecurity #NationalSecurity #DefenseTech #FedRAMP #CMMC #ATO #ArtificialIntelligence #GovTech #CyberCompliance #CloudSecurity #KovrAI #DoD #ZeroTrust #EmergingTech #Startup #MachineLearning #CyberDefense #FutureOfAI #GovernmentTechnology Support the show

    36 min
See All (857)

Ratings & Reviews

5
out of 5
6 Ratings

About

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

Information

You Might Also Like